Modulatory effects in the cannabinoid system through the inhibition of the activities of the fatty acid amide hydrolase (FAAH) and the monoacylglycerol lipase (MAGL) enzymes may serve as therapeutic potentials in treating disorders such as mood and anxiety [11]. This evidence concerns the gene MGLL and Anxiety.